International equity exposure has re-emerged as a key allocation debate, as investors weigh valuation gaps, a shifting U.S. dollar, and concentrated domestic markets. These two funds represent sharply different ways to pursue the same broad goal of diversifying beyond U.S. borders. AVNM (Avantis All International Markets Equity ETF) takes an active, factor-driven approach spanning both developed and emerging markets, while VEA (Vanguard FTSE Developed Markets ETF) delivers broad, low-cost, market-cap-weighted coverage of developed economies only. They do not compete directly on structure, but they do compete for the same investor dollar, making their relative positioning worth understanding in the current market environment. I also checked this using Tickeron’s AI Screener to see how the two compare to peers in the international equity space.
Launched in June 2023 and managed by American Century Investments, AVNM is an actively managed fund-of-funds. Rather than holding individual stocks directly, it invests in a set of roughly eight underlying Avantis ETFs to construct a globally diversified international equity portfolio. Its largest sleeves include AVDE (Avantis International Equity ETF, about 40%), AVIV (International Large Cap Value, about 20%), AVEM (Emerging Markets Equity, about 18%), AVES (Emerging Markets Value, about 10%), and AVDV (International Small Cap Value, about 7%).
The strategy tilts toward securities expected to offer higher returns or better risk characteristics than a market-cap-weighted index, emphasizing value, small-cap, and profitability factors. Sector allocation is led by financials (roughly 23%), industrials (about 17%), and basic materials (about 13%), with a notable emerging-markets weight of roughly 25%. Geographically, Japan, Canada, and the U.K. are the largest exposures, with China and Taiwan also represented. The net expense ratio is 0.31%, and the fund's smaller asset base means relatively lower trading liquidity compared with mega-cap peers.
VEA, launched in July 2007, is a passively managed index fund that seeks to track the FTSE Developed All Cap ex US Index. This market-capitalization-weighted benchmark holds roughly 3,900 to 3,950 large-, mid-, and small-cap stocks across developed markets outside the United States, making it one of the broadest and most established vehicles in the category. With hundreds of billions of dollars in assets, it is among the most liquid international equity ETFs available.
Its top holdings are familiar global blue chips, including Samsung Electronics, SK Hynix, ASML Holding, HSBC Holdings, Roche Holding, Shell, Royal Bank of Canada, Novartis, Mitsubishi UFJ Financial Group, and AstraZeneca — though no single position exceeds roughly 3% of the portfolio. Sector exposure is led by financials (about 24%) and industrials (about 18%), followed by technology and healthcare. The fund carries an exceptionally low expense ratio of about 0.03%. Because it tracks a developed-markets-only index, it excludes emerging economies entirely.
Both funds sit at the intersection of several powerful macro forces. A softer U.S. dollar and relatively cheaper international valuations have renewed interest in non-U.S. equities, while Japan's ongoing corporate-governance reforms and shareholder-return push have supported developed-market performance. At the same time, artificial-intelligence and semiconductor demand have boosted heavyweight Asian and European technology names such as Samsung Electronics, SK Hynix, and ASML Holding, which feature prominently in VEA's portfolio.
Rate expectations in Europe and Japan, energy-price swings, and geopolitical tensions in Europe and Asia continue to shape relative returns. A key risk is currency: unhedged international exposure means both funds are sensitive to exchange-rate movements. The contrast in sector exposure — AVNM's heavier tilt toward financials and basic materials versus VEA's broader, more market-neutral allocation — also means the two funds respond differently to value-versus-growth rotations.
In recent market cycles, both funds have benefited from strength in international equities, but their drivers differ. VEA's performance has leaned on large-cap developed-market leaders, particularly in technology and financials, and its low cost has helped it capture index returns efficiently. AVNM's factor tilts toward value and small-cap names, plus its emerging-markets sleeve, have introduced greater dispersion — adding return potential in value-led stretches but also additional volatility and tracking divergence from a plain market-cap benchmark.
From a relative positioning standpoint, VEA offers steadier, broader diversification with minimal cost drag and higher liquidity, while AVNM represents a more concentrated active bet on factor premia and emerging-market growth. Investors weighing these funds are essentially choosing between passive, low-cost core exposure and an actively managed, factor-enhanced satellite allocation.
In the course of my research, I often turn to Tickeron’s AI Screener to filter ETFs and stocks by technical patterns, fundamentals, trends, and performance metrics. It helps me quickly compare options like these two funds against broader industry peers and identify which characteristics stand out most clearly for a given allocation goal.
Based on observable structural factors, Tickeron's AI would currently favor VEA. Its ultra-low 0.03% expense ratio, near-4,000-stock diversification, deep liquidity, and disciplined passive index replication give it superior cost efficiency and structural strength. While AVNM's factor tilts and emerging-markets exposure may offer differentiated return potential in certain environments, those advantages come with higher fees, thinner liquidity, and greater volatility. For a core, cost-conscious international allocation, VEA's combination of breadth, scale, and consistency makes it the more compelling choice in this comparison — though AVNM may still appeal as a complementary, factor-driven satellite.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where VEA declined for three days, in 208 of 259 cases, the price declined further within the following month. The odds of a continued downward trend are 80%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VEA as a result. In 62 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for VEA turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 35 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
The Aroon Indicator for VEA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where VEA advanced for three days, in 266 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
VEA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows